Overview

A Clinical Trial to Demonstrate the Efficacy of Cangrelor

Status:
Terminated
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to demonstrate that the efficacy of cangrelor is superior, or at least non-inferior, to that of clopidogrel in subjects requiring PCI.
Phase:
Phase 3
Details
Lead Sponsor:
The Medicines Company
Treatments:
Cangrelor
Clopidogrel
Ticlopidine